Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China
· Delayed Price · Currency is CNY 35.20
-0.24 (-0.68%)
At close: Apr 25, 2025, 2:57 PM CST
SHA:688193 Revenue
In the year 2024, Shanghai Rendu Biotechnology had annual revenue of 177.35M CNY with 7.87% growth. Shanghai Rendu Biotechnology had revenue of 46.71M in the quarter ending December 31, 2024, a decrease of -1.28%.
Revenue
177.35M
Revenue Growth
+7.87%
P/S Ratio
7.81
Revenue / Employee
495.40K
Employees
358
Market Cap
1.39B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.79B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Shanghai United Imaging Healthcare | 10.30B |